TW306921B - - Google Patents

Download PDF

Info

Publication number
TW306921B
TW306921B TW081109648A TW81109648A TW306921B TW 306921 B TW306921 B TW 306921B TW 081109648 A TW081109648 A TW 081109648A TW 81109648 A TW81109648 A TW 81109648A TW 306921 B TW306921 B TW 306921B
Authority
TW
Taiwan
Prior art keywords
compound
item
patent application
formula
alkyl
Prior art date
Application number
TW081109648A
Other languages
English (en)
Chinese (zh)
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Application granted granted Critical
Publication of TW306921B publication Critical patent/TW306921B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW081109648A 1991-12-05 1992-12-02 TW306921B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919125900A GB9125900D0 (en) 1991-12-05 1991-12-05 Piperazine derivatives

Publications (1)

Publication Number Publication Date
TW306921B true TW306921B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1997-06-01

Family

ID=10705770

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081109648A TW306921B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-12-05 1992-12-02

Country Status (22)

Country Link
US (1) US5710149A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0625977B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3262333B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100244626B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE162527T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU658242B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9206861A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2124680C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69224212T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0625977T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2111654T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI942635L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB9125900D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3025988T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (2) HUT70755A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL103944A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9206939A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ246007A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2125566C1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW306921B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1993011122A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA929317B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8322764B2 (en) 2010-06-11 2012-12-04 Mag-Lok Tools, Inc. Modular long handled tool component system

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9300195D0 (en) * 1993-01-06 1993-03-03 Wyeth John & Brother Ltd Piperazine derivatives
US5609849A (en) * 1994-03-11 1997-03-11 The Trustees Of The University Of Pennsylvania Serotonin (5-HT1A) receptor ligands and imaging agents
US5434158A (en) * 1994-04-26 1995-07-18 Merck & Co., Inc. Spiro-substituted azacycles as neurokinin-3 antagonists
GB9419024D0 (en) * 1994-09-21 1994-11-09 Wyeth John & Brother Ltd Bicyclic carboxamides
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
US5466688A (en) * 1994-10-20 1995-11-14 American Home Products Corporation Pyrido[3,4-B]indole derivatives as serotonergic agents
US5439915A (en) * 1994-10-20 1995-08-08 American Home Products Corporation Pyrido[3,4-B]indole carboxamide derivatives as serotonergic agents
US5451584A (en) * 1994-11-10 1995-09-19 American Home Products Corporation N-alkynyl carboxamides as sertonergic agents
US5541179A (en) * 1995-05-02 1996-07-30 American Home Products Corporation Tropon-2-one piperazine carboxamides as serotonergic agents
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
US5610164A (en) * 1996-07-24 1997-03-11 American Home Products Corporation (Thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides
US6482827B1 (en) * 1997-07-10 2002-11-19 Pharmacia & Upjohn S.P.A. Matrix metalloproteinase inhibitors
US6376494B1 (en) 1998-06-15 2002-04-23 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
JP2002518382A (ja) * 1998-06-15 2002-06-25 アメリカン・ホーム・プロダクツ・コーポレイション セロトニン作動薬としてのシクロアルキル−置換アリール−ピペラジン、ピペリジンおよびテトラヒドロピリジン
PE20001420A1 (es) 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
US7217714B1 (en) 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
US20060287335A1 (en) * 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
EP1408976B3 (en) 2001-07-20 2010-08-25 Psychogenics Inc. Treatment for attention-deficit hyperactivity disorder
MXPA04008730A (es) * 2002-03-12 2004-12-06 Wyeth Corp Proceso para preparacion de piperazinas quirales 1,4-disustituidas.
NZ535168A (en) * 2002-03-12 2006-03-31 Wyeth Corp Process for synthesizing chiral N-aryl piperazines
ITMI20021327A1 (it) * 2002-06-14 2003-12-15 Recordati Chem Pharm Nuove ossialchilpiperazine
KR100755580B1 (ko) * 2002-12-03 2007-09-06 에프. 호프만-라 로슈 아게 Cns-장애의 치료를 위한 5-ht6-수용체 리간드로서의아미노알콕시인돌
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
US20070099931A1 (en) * 2004-03-19 2007-05-03 Wyeth Pharmaceutical dosage forms and compositions
US20050209245A1 (en) * 2004-03-19 2005-09-22 Wyeth Process for preparing N-aryl-piperazine derivatives
JP2008531694A (ja) * 2005-03-01 2008-08-14 ワイス 結晶性および非晶性4−シアノ−n−{(2r)−2−[4−(2,3−ジヒドロ−ベンゾ[1,4]ジオキシン−5−イル)−ピペラジン−1−イル]−プロピル}−n−ピリジン−2−イル−ベンズアミド塩酸塩
US7731940B2 (en) 2006-01-25 2010-06-08 The Regents Of The University Of California Compositions and methods related to serotonin 5-HT1A receptors
US9066903B2 (en) 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease
AU2008251259B2 (en) * 2007-05-14 2013-02-14 Sk Biopharmaceuticals Co., Ltd. Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
US8367676B2 (en) * 2009-06-30 2013-02-05 Astrazeneca Ab 2-carboxamide-7-piperazinyl-benzofuran derivatives 774

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU534071A1 (ru) * 1974-03-26 1980-04-30 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвийской Сср -Замещенные пиперазины,обладающие психотропной активностью
DK169601B1 (da) * 1983-10-17 1994-12-19 Duphar Int Res Piperazinderivater og farmaceutisk præparat indeholdende et sådant derivat, samt piperazinderivater med mellemproduktanvendelse
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
US5340812A (en) * 1989-04-22 1994-08-23 John Wyeth & Brother, Limited Piperazine derivatives
US5382583A (en) * 1989-04-22 1995-01-17 John Wyeth & Brother, Limited Piperazine derivatives
IE64038B1 (en) * 1989-04-22 1995-06-28 Wyeth John & Brother Ltd Tertiary alkyl functionalized piperazine derivatives
EP0395312B1 (en) * 1989-04-22 1999-05-12 JOHN WYETH & BROTHER LIMITED Piperazine derivatives
US4935511A (en) * 1989-09-26 1990-06-19 Rorer Pharmaceutical Corporation Benzoxazine and benzoxazepine carboxamide 5-HT3 antagonists
GB9022820D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives
GB9022790D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives
FR2670491B1 (fr) * 1990-12-14 1993-02-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
GB9112697D0 (en) * 1991-06-13 1991-07-31 Shell Int Research Biocidal compounds
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
GB9308725D0 (en) * 1993-04-27 1993-06-09 Wyeth John & Brother Ltd Piperazine derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8322764B2 (en) 2010-06-11 2012-12-04 Mag-Lok Tools, Inc. Modular long handled tool component system

Also Published As

Publication number Publication date
DE69224212D1 (de) 1998-02-26
FI942635A7 (fi) 1994-06-03
GB9225121D0 (en) 1993-01-20
WO1993011122A1 (en) 1993-06-10
AU2953792A (en) 1993-06-28
EP0625977B1 (en) 1998-01-21
RU2125566C1 (ru) 1999-01-27
FI942635A0 (fi) 1994-06-03
US5710149A (en) 1998-01-20
JPH07501803A (ja) 1995-02-23
RU94030476A (ru) 1996-04-20
AU658242B2 (en) 1995-04-06
MX9206939A (es) 1993-06-01
DK0625977T3 (da) 1998-05-04
EP0625977A1 (en) 1994-11-30
IL103944A0 (en) 1993-05-13
CA2124680A1 (en) 1993-06-10
KR100244626B1 (ko) 2000-05-01
GB2262093B (en) 1995-06-07
DE69224212T2 (de) 1998-04-30
ZA929317B (en) 1994-06-01
HU211518A9 (en) 1995-11-28
HU9401686D0 (en) 1994-09-28
NZ246007A (en) 1995-04-27
GB2262093A (en) 1993-06-09
GB9125900D0 (en) 1992-02-05
IL103944A (en) 1997-06-10
CA2124680C (en) 2004-02-17
ES2111654T3 (es) 1998-03-16
HUT70755A (en) 1995-10-30
GR3025988T3 (en) 1998-04-30
ATE162527T1 (de) 1998-02-15
BR9206861A (pt) 1995-11-21
FI942635L (fi) 1994-06-03
JP3262333B2 (ja) 2002-03-04

Similar Documents

Publication Publication Date Title
TW306921B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP3274865B2 (ja) 5−htレセプター拮抗物質としてのピペラジン誘導体
EP1261601B1 (de) Substituierte indole zur modulierung von nfkb-aktivität
JP3087763B2 (ja) 新規な複素環式化合物およびそれを含有する医薬組成物
TW442482B (en) Use of 1-benzyl-3-(substituted hetaryl)-fused pyrazole derivatives
CN105102448B (zh) 作为rock1和rock2抑制剂的苯基吡唑衍生物
AU2015227454B2 (en) Functionalised and substituted indoles as anti-cancer agents
JP5897566B2 (ja) 環式n,n’−ジアリールチオ尿素及びn,n’−ジアリール尿素−アンドロゲン受容体アンタゴニスト、抗癌剤、その調製のための方法及び使用
NZ229239A (en) Substituted diperazine derivatives and pharmaceutical compositions
JP2004520382A (ja) ムスカリン受容体アゴニスト
CN109195963A (zh) 作为apj激动剂的6-羟基-4-氧代-1,4-二氢嘧啶-5-甲酰胺
BRPI0712730A2 (pt) Composto da fórmula i; método para o tratamento de um distúrbio do sistema nervoso central relacionado ou afetado pelo receptor 5-ht6 em um paciente que dele necessita; composição farmacêutica; processo para a preparação de um composto da fórmula ia; e uso de um composto da fórmula i
JP2009523751A (ja) Mdm2阻害剤としてのシス−4,5−ビアリール−2−ヘテロサイクリック−イミダゾリン
TW472054B (en) Azetidines
PT98768B (pt) Processo de preparacao de derivados de piperazinilo e de composicoes farmaceuticas que os contem
JP4076234B2 (ja) テトラヒドロベンズインドール化合物
DE69321609T2 (de) Piperazinderivate
CN1096459C (zh) (r)-5-溴-n-(1-乙基-4-甲基六氢-1h-1,4-二氮杂䓬-6-基)-2-甲氧基-6-甲胺基-3-吡啶羧酰胺,其制备方法及含有该化合物的医药组合物
KR100768021B1 (ko) 시스-2,4,5-트리아릴-이미다졸린
DE69713110T2 (de) 4-aminoethoxy-indolon-derivate
JP3077047B2 (ja) 新規ピペラジン誘導体
JP2002513015A (ja) セロトニン作動薬としてのインドリル誘導体
TW593294B (en) Polycyclic thiazole systems having anorectic activity, processes for their preparation and pharmaceutical composition comprising these compounds
JPS6248668A (ja) キノリン誘導体とその酸付加塩、その製法及びこの化合物を含む薬用組成物
JP2883970B2 (ja) 新規1,4−(ジフェニルアルキル)ピペラジン誘導体